These ASX 200 shares could rise 25% to 60%

Brokers are tipping these shares to deliver outsized returns for investors.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are hunting for big returns for your investment portfolio, then look no further than the ASX 200 shares in this article.

That's because analysts are tipping them to rise by 25%+ over the next 12 months. Here's what you need to know about them:

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.

Image source: Getty Images

Flight Centre Travel Group Ltd (ASX: FLT)

The team at Macquarie thinks that this travel agent giant is a cheap ASX 200 share to buy right now.

While it wasn't blown away with its full year results in FY 2025, it believes its valuation is attractive and expects improvements in macro conditions to drive strong performances from its key segments. It said:

Outperform. While profit disappointed, both segments delivered solid TTV growth which should accelerate if macro conditions are more supportive. Valuation is attractive, and we see material upside to the current share price over a 12m view.

Macquarie has an outperform rating and $16.55 price target on Flight Centre's shares. Based on its current share price of $13.03, this implies potential upside of 27% for investors over the next 12 months.

In addition, it is forecasting a fully franked dividend yield of 3% in FY 2026, which boosts the total potential return to 30%.

Telix Pharmaceuticals Ltd (ASX: TLX)

Analysts at Bell Potter think that big returns could be coming for patient investors with this beaten down radiopharmaceuticals company's shares.

Although it concedes that this year has been tough for approvals (most recently the denial of Zircaix by the US FDA), it remains very positive on its longer term outlook and appears to see the recent share price weakness as a buying opportunity. It said:

The previous forecast included modest revenues from Zircaix in FY26 ($31m) which is now stripped out and EBITDA is reduced by $13m. The company does not plan to curtail any R&D spend at this point as it remains well capitalised and we expect will continue to generate cash from operations. This is the second CRL for TLX this calendar year. The delay to revenues and knock on effect to the cost of capital (risk) and valuation are material, accordingly our TP is reduced.

Bell Potter has put a buy rating and $23.00 price target on the ASX 200 share. Based on its current share price of $14.60, this suggests that upside of almost 60% is possible for investors between now and this time next year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Flight Centre Travel Group and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A man looking at his laptop and thinking.
Broker Notes

What is Morgans saying about A2 Milk and these ASX shares?

Let's see what the broker is saying about these names.

Read more »

A woman with bright yellow hair wearing a brightly patterned blouse reacts to big news that she's reading on her phone.
Broker Notes

What does this broker have to say about Cleanaway Waste Management and Capstone Copper shares?

These shares have 20% to 30% upside.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Broker Notes

Why this surging ASX All Ords gold stock is tipped to rocket another 79%

A leading broker forecasts more outsized gains from this fast-rising ASX gold stock. But why?

Read more »

A person working on a computer holds a lightbulb that is connected to the network and shining brightly.
Broker Notes

Origin Energy shares: Experts argue the case to buy, hold, and sell

Three experts present three different ratings.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

What is Bell Potter saying about A2 Milk shares after the selloff?

Is this a buy, hold, or sell after Monday's weakness? Let's find out.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Broker Notes

Forget CBA shares and buy this ASX 200 stock: Shaw & Partners

Let's see what the broker is saying about these stocks.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on CBA and Woodside shares

A top analyst foresees mounting headwinds for CBA and Woodside shares.

Read more »